265TiP SOLTI-2201 ACROSS-TROP2 trial: A phase II study to identify predictive biomarkers of sacituzumab govitecan benefit and to understand resistance mechanisms in HR+/HER2- advanced or metastatic breast cancer

E.M. Ciruelos, T. Pascual,R. Villanueva Vazquez, J.M. Cejalvo, K. Amillano Parraga,F.J. Salvador Bofill, I. Blancas López-Barajas, A. Ferrando Diez, Y. Izarzugaza Peron,M. Borrell Puy, A. Fernandez-Martinez,G. Villacampa Javierre, J.M. Ferrero-Cafiero, M. Paes Dias,F. Salvador, M. Oliveira

ESMO Open(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要